{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:40:43Z","timestamp":1755222043422,"version":"3.43.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515030272"],"award-info":[{"award-number":["2024A1515030272"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.imbio.2025.153096","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:27:22Z","timestamp":1751423242000},"page":"153096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low peripheral blood B lymphocyte count predicts poor outcome in patients with multiple myeloma"],"prefix":"10.1016","volume":"230","author":[{"given":"Yuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoxi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2025.153096_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112822","article-title":"Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined significance and Multiple Myeloma","volume":"20","author":"Allegra","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2025.153096_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.830922","article-title":"Risk Stratification before and during Treatment in newly Diagnosed Multiple Myeloma: from Clinical Trials to the Real-World setting","volume":"12","author":"Bonello","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.imbio.2025.153096_bb0015","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1007\/s10238-023-01232-9","article-title":"Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy","volume":"23","author":"Cheng","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.imbio.2025.153096_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2013.04.004","article-title":"Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)","volume":"27","author":"Feyler","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.imbio.2025.153096_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/2040620718822660","article-title":"Immunotherapy in myeloma: how far have we come?","volume":"10","author":"Franssen","year":"2019","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.imbio.2025.153096_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020217","article-title":"The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.imbio.2025.153096_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41408-022-00679-5","article-title":"High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions","volume":"12","author":"Hagen","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.imbio.2025.153096_bb0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","article-title":"Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT","volume":"1","author":"Ho","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.imbio.2025.153096_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clml.2016.06.001","article-title":"Revised International Staging System Applied to Real World Multiple Myeloma patients","volume":"16","author":"Jimenez-Zepeda","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.imbio.2025.153096_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V90.1.340.340_340_345","article-title":"Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial","volume":"90","author":"Kay","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2025.153096_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V98.1.23","article-title":"Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients","volume":"98","author":"Kay","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2025.153096_bb0060","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","article-title":"B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2025.153096_bb0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood.V76.7.1375.1375","article-title":"Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival","volume":"76","author":"Omed\u00e9","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2025.153096_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3324\/haematol.2012.067272","article-title":"Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry","volume":"98","author":"Pessoa de Magalh\u00e3es","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2025.153096_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.imbio.2025.153096_bb0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4132\/KoreanJPathol.2013.47.6.526","article-title":"Prognostic significance of absolute lymphocyte count\/absolute monocyte count ratio at diagnosis in patients with multiple myeloma","volume":"47","author":"Shin","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.imbio.2025.153096_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-022-01234-2","article-title":"Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma","volume":"15","author":"Swamydas","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.imbio.2025.153096_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.stemcr.2016.06.009","article-title":"Distinctive Mesenchymal-Parenchymal Cell Pairings govern B Cell Differentiation in the Bone Marrow","volume":"7","author":"Yu","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.imbio.2025.153096_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663748","article-title":"Predictive Role of Immune Profiling for Survival of Multiple Myeloma patients","volume":"12","author":"Zhaoyun","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852500230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852500230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T22:59:05Z","timestamp":1754780345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129852500230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S017129852500230X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153096","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low peripheral blood B lymphocyte count predicts poor outcome in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153096"}}